|
|
Use of Long-Acting Injectables for HIV Treatment and Prevention: A Clinical Update
Recorded for 2025 Fall Conference
|
|
Facebook
LinkedIn
E-Mail
|
(715)
|
Activity Duration| Content Expires: | February 28, 2027 (11:55 p.m. CT) CE for this activity will not be available after this date. | This CE activity was recorded for the 2025 AANP Fall Conference.  | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the virtual 2025 AANP Fall Conference. If you already completed the content of this activity while attending the virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview This presentation will provide a clinical overview of the latest advances in the use of long-acting injectables for the treatment and prevention of HIV infection. Information on patient selection, monitoring, and follow-up will be reviewed. Challenges and strategies to overcome barriers to implementation in clinical practice will also be highlighted. Objectives
- Identify at least 3 criteria that clinicians should consider when prescribing long-acting injectables in persons with HIV.
- Identify at least 3 criteria that clinicians should consider when prescribing long-acting injectables as HIV pre-exposure prophylaxis in persons vulnerable to HIV infection.
- List at least 3 common side effects of long-acting injectables used for HIV treatment and/or prevention, and ways to address these effects.
- State at least 3 key considerations for monitoring patients on long-acting injectable antiretrovirals.
- Describe at least 1 strategy to improve the uptake of long-acting injectables in clinical practice.
Speaker Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN
Disclosure This program was planned in accordance with AANP CE Standards and Policies. The speaker has the following disclosures:- I have nothing to disclose.
DisclaimerIndividuals who have contributed to the CE Center (content originally from the 2025 AANP Fall Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.13 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand) MODULE 6: Opioid Prescribing Update
(OnDemand) MODULE 7: Buprenorphine and Methadone
(OnDemand) MODULE 1: Pathophysiology of Pain and Neurobiology of Addiction Overview
(OnDemand) MODULE 3: Non-Opioid Pharmacology Treatment of Pain
(OnDemand) MODULE 8: Special Populations and Opioid Use Disorder Treatment
(OnDemand) MODULE 5: Substance Use Disorders - Opioids
(OnDemand) 2025 Syphilis Update: What You Need to Know
(OnDemand) MODULE 4: Care Transitions and New Frontiers in SUD Treatment
(OnDemand) MODULE 2: Non-Pharmacologic Treatment of Pain
(OnDemand) Migraine, Diagnosis and Treatment Tried, True and New
(OnDemand) Autoimmune Diseases in Dermatology: Diagnosis, Management, and Clinical Pearls
(OnDemand) Managing Insomnia
|
|